Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Nuvation Bio Inc shares valued at $162,883 were sold by Wang Junyuan Jerry on Nov 11 ’24. At $2.89 per share, Wang Junyuan Jerry sold 56,361 shares. The insider’s holdings dropped to 3,866,228 shares worth approximately $10.71 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Mashal Robert purchased 100,000 shares, netting a total of over 220,000 in proceeds. Following the buying of shares at $2.20 each, the insider now holds 100,000 shares.
Before that, Cui Xiangmin had added 277,895 shares to its account. In a trade valued at $825,348, the Director bought Nuvation Bio Inc shares for $2.97 each. Upon closing the transaction, the insider’s holdings increased to 277,895 shares, worth approximately $6.8 million.
As published in a research note from Jefferies on March 27, 2024, Nuvation Bio Inc [NUVB] has been rated up from a Hold to a Buy and the price target has been revised to $10 from $1.40. Analysts at BTIG Research upgraded the stock from ‘”a Neutral”‘ to ‘”a Buy”‘ outlook in a report released in late March. As of January 06, 2023, Jefferies has decreased its “Buy” rating to a “Hold” for NUVB. Earlier on August 02, 2022, BTIG Research downgraded its rating. Their new recommendation was “a Neutral” for NUVB stock which previously was a “a Buy”.
Analyzing NUVB Stock Performance
During the last five days, there has been a drop of approximately -4.15%. Over the course of the year, Nuvation Bio Inc shares have jumped approximately 83.44%. Shares of the company reached a 52-week high of $4.16 on 03/28/24 and a 52-week low of $1.43 on 01/18/24. A 50-day SMA is recorded $2.52, while a 200-day SMA reached $2.83. Nevertheless, trading volume fell to 1.61 million shares from 4.14 million shares the previous day.
Support And Resistance Levels for Nuvation Bio Inc (NUVB)
According to the 24-hour chart, there is a support level at 2.72, which, if violated, would cause prices to drop to 2.67. In the upper region, resistance lies at 2.82. The next price resistance is at 2.87. RSI (Relative Strength Index) is 52.58 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.03, which suggests the price will decrease in the coming days. Percent R is at 45.53%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
